Source: Pall Corporation
Sunday, March 21, 2010
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--
Pall Corporation, (NYSE: PLL), a global leader in filtration, separation
and purification, has announced a long-term joint marketing agreement
with SOTAX Group that will include Pall Acrodisc® PSF syringe
filters in all SOTAX dissolution systems for solid dosage forms. The
exclusive agreement is the initial step that allows the companies to
begin delivering complete certification solutions that save time and
testing costs for quality control laboratories.
advertisement
Pall Acrodisc PSF syringe filters are used by research and analytical
laboratories to help expedite automated sample processing. First
introduced in 1973, Pall’s Acrodisc syringe filters provide improved
retention efficiency to help extend HPLC column life by as much as 46
times. The multi-layered prefilter provides two to four times the
throughput of standard glass fiber prefilter devices to allow for quick
and easy filtration of samples that are difficult to filter. The PSF
housing has been designed for smooth operation in automated systems and
operating pressures, eliminating filter burst.
SOTAX is a Swiss-based provider of high-quality dissolution testing
systems, composite assay and content uniformity workstations along with
physical tablet testing instruments for the pharmaceutical industry.
Dissolution testing is used by the pharmaceutical industry to
characterize the dissolution properties of an active drug, an active
drug's release and the dissolution from a dosage formulation. SOTAX
systems formulate the drug dosage form and develop quality control
specifications for the manufacturing process.
“By exclusively recommending Pall Acrodisc PSF technology as part of our
testing systems, we can ensure we are providing the pharmaceutical
industry with a significantly improved automated dissolution process for
multiple unattended tests. This includes applications for media
preparation and delivery, automated dosage introduction, automated
sampling, filtering and sample analysis,” said Gilles Devidts, Head of
Product Management, SOTAX.
At the start of this agreement, all new SOTAX AT 70smart Dissolution
systems and SOTAX CTS Content Uniformity test systems will include the
Pall Acrodisc PSF syringe filters. Filter refills will be available
directly from Pall Life Sciences through its regular sales and
distribution channel.
“This marketing partnership with SOTAX advances the performance of the
automated laboratory analysis platform,” said Larry O’Connell, Senior
Vice President, Global Lab Products for Pall Life Sciences. “Customers
can now obtain the dual benefits associated with SOTAX and Pall
technology to achieve superior analysis and performance.”
To learn more about Acrodisc PSF syringe filters, visit www.pall.com/lab
.
To order, call 1-800-521-1520 in the U.S./Canada or (+)800-PALL-LIFE in
all other locations. E-mail Pall Life Sciences at LabCustomerSupport@pall.com
.
Pall Life Sciences
Pall Life Sciences provides cutting-edge products and services to meet
the demanding needs of customers discovering, developing and producing
biotech drugs, vaccines and classic pharmaceuticals. Pall technologies
are also used to collect and process blood components and help protect
patients from hospital-acquired infections. The company’s membranes and
membrane devices optimize detection and sample preparation in the drug
research, clinical diagnostics, genomics, and proteomics markets. Pall
is a leading provider of separation systems and single-use filtration
and purification technologies to pharmaceutical and biotechnology
companies to support faster development of new drugs and vaccines that
are safer and require less energy and water to produce.
About Pall Corporation
Pall Corporation (NYSE:PLL) is a filtration, separation and purification
leader providing Total Fluid ManagementSM solutions to meet
the critical needs of customers in biopharmaceutical; hospital,
transfusion and veterinary medicine; energy and alternative energy;
electronics; municipal and industrial water; aerospace; transportation
and broad industrial markets. Together with our customers, we foster
health, safety and environmentally responsible technologies. The
Company’s engineered solutions enable process and product innovation and
minimize emissions and waste. Pall Corporation, with total revenues of
$2.3 billion for fiscal 2009, is a S&P 500 company with more than 10,000
employees servicing customers worldwide. Pall has been named a
top "green company" by Newsweek magazine. To see how
Pall is helping enable a greener and more sustainable future, visit www.pall.com.
Note to Editors: A high-resolution photograph of the Acrodisc
PSF syringe filter is available for download at www.pall.com/news
www.pall.com/lab
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6220206&lang=en